Liste des médicaments et vaccins
| DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
|---|---|---|---|---|---|---|
| IPPZOR 15 15mg Gélule B/28 | LANSOPRAZOLE | TERIAK S.A | Tunisie | 2427.04 | AMM_2019_5346 | 2026-05-31 |
| IPPZOR 30 30mg Gélule gastro-résistante B/28 | LANSOPRAZOLE | TERIAK S.A | Tunisie | 4460.51 | AMM_2019_5347 | 2027-06-30 |
| IRBESARTAN BGR 150mg Comprimé pelliculé B/30 | IRBESARTAN | BIOGARAN | Portugal | 2951.81 | AMM_2018_4434 | 2026-03-31 |
| IRBESARTAN BGR 300mg Comprimé pelliculé B/30 | IRBESARTAN | BIOGARAN | Portugal | 3410.98 | AMM_2018_4432 | 2025-11-09 |
| IRBESARTAN BGR 75mg Comprimé pelliculé B/30 | IRBESARTAN | BIOGARAN | Portugal | 2184.34 | AMM_2018_4433 | 2026-03-31 |
| IRBESARTAN/AMLODIPINE BESYLATE IMPACT 150mg+5mg Comprimé pelliculé B/28 | IRBESARTAN + AMLODIPINE | SANOFI-AVENTIS FRANCE | Turquie | 2295.85 | AMM_2025_20942 | 2031-02-28 |
| IRBESARTAN/AMLODIPINE BESYLATE IMPACT 300mg+10mg Comprimé pelliculé B/28 | IRBESARTAN + AMLODIPINE | SANOFI-AVENTIS FRANCE | Turquie | 3935.74 | AMM_2025_21107 | 2031-02-28 |
| IRBESARTAN/AMLODIPINE BESYLATE IMPACT 300mg+5mg Comprimé pelliculé B/28 | IRBESARTAN + AMLODIPINE | SANOFI-AVENTIS FRANCE | Turquie | 3279.78 | AMM_2025_21105 | 2031-02-28 |